KPC Pharmaceuticals,Inc. (SHA:600422)
China flag China · Delayed Price · Currency is CNY
9.50
+0.01 (0.11%)
Apr 29, 2026, 3:00 PM CST

KPC Pharmaceuticals,Inc. Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,1849,50811,99815,81210,7078,379
Market Cap Growth
-44.89%-20.76%-24.12%47.68%27.78%27.75%
Enterprise Value
8,7519,98810,97915,19510,6547,992
Last Close Price
9.4912.5615.5320.1613.5310.34
PE Ratio
61.1927.1718.5129.2427.9416.50
Forward PE
22.7313.0118.2423.0817.5413.16
PS Ratio
1.241.451.431.881.291.01
PB Ratio
1.061.371.781.992.081.70
P/TBV Ratio
2.142.723.593.422.361.96
P/FCF Ratio
-47.8616.4724.5370.37542.13
P/OCF Ratio
-32.8714.8520.9642.1733.30
PEG Ratio
-1.181.181.181.181.18
EV/Sales Ratio
1.511.521.311.801.290.97
EV/EBITDA Ratio
61.3123.3611.0817.4314.3214.07
EV/EBIT Ratio
-37.2613.4521.8218.9119.53
EV/FCF Ratio
-29.7050.2715.0723.5770.02517.08
Debt / Equity Ratio
0.240.240.120.110.220.17
Debt / EBITDA Ratio
11.323.710.820.991.481.40
Debt / FCF Ratio
-8.481.141.407.4953.57
Net Debt / Equity Ratio
0.00-0.09-0.28-0.15-0.16-0.18
Net Debt / EBITDA Ratio
-0.07-1.54-1.92-1.38-1.13-1.60
Net Debt / FCF Ratio
0.03-3.31-2.61-1.86-5.51-58.67
Asset Turnover
0.490.540.680.780.900.97
Inventory Turnover
2.372.782.882.632.722.70
Quick Ratio
1.551.581.221.591.211.12
Current Ratio
2.092.021.562.111.741.77
Return on Equity (ROE)
2.35%6.12%10.22%9.81%7.65%10.76%
Return on Assets (ROA)
-0.21%1.37%4.10%4.01%3.84%2.99%
Return on Invested Capital (ROIC)
-0.52%4.26%11.32%10.30%10.92%8.71%
Return on Capital Employed (ROCE)
-0.50%3.40%11.50%8.30%10.20%7.60%
Earnings Yield
1.64%3.68%5.40%3.42%3.58%6.06%
FCF Yield
-4.10%2.09%6.07%4.08%1.42%0.18%
Dividend Yield
1.90%1.43%1.93%0.99%1.18%2.61%
Payout Ratio
237.17%80.03%26.62%27.11%60.37%40.10%
Buyback Yield / Dilution
-1.30%-0.95%1.05%-1.36%0.84%0.19%
Total Shareholder Return
0.53%0.48%2.98%-0.37%2.02%2.80%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.